Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy

References

• Grohskopf LA, Sokolow LZ, Broder KR, Olsen SJ, Karron RA, Jernigan DB, Bresee JS. Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep. 2016;65:1-54. doi:10.15585/mmwr.rr6505a1.
   PubMed Web of Science ®Google Scholar
• Bonanni P, Boccalini S, Zanobini P, Dakka N, Lorini C, Santomauro F, Bechini A. The appropriateness of the use of influenza vaccines: Recommendations from the latest seasons in Italy. Hum Vaccin Immunother. 2018;14(3):699–705. doi:10.1080/21645515.2017.1388480.
   PubMed Web of Science ®Google Scholar
• Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother. 2012;8:81-8. doi:10.4161/hv.8.1.17623.
   PubMed Web of Science ®Google Scholar
• Australian Government Deptartment of Health. Australian influenza report no. 10; 2015 [accessed 2017 May 10]. http://www.health.gov.au/internet/main/publishing.nsf/Content/5BAB80E0DC5A47DBCA257EE400130AD3/$File/Australian-Influenza-Surveillance-Report.pdf.
   Google Scholar
• Caini S, Huang QS, Ciblak MA, Kusznierz G, Owen R, Wangchuk S, Henriques CM, Njouom R, Fasce RA, Yu H, et al. Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study. Influenza Other Respir Viruses. 2015;9(Suppl 1):3-12. doi:10.1111/irv.12319.
   PubMedGoogle Scholar
• Crepey P, de Boer PT, Postma MJ, Pitman R. Retrospective public health impact of a quadrivalent influenza vaccine in the United States. Influenza Other Respir Viruses. 2015;9(Suppl 1):39-46. doi:10.1111/irv.12318.
   PubMed Web of Science ®Google Scholar
• Moa AM, Muscatello DJ, Turner RM, MacIntyre CR. Epidemiology of influenza B in Australia: 2001–2014 influenza seasons. Influenza Other Respir Viruses. 2017;11:102-9. doi:10.1111/irv.12432.
   PubMed Web of Science ®Google Scholar
• Sternal J, Hammond A, Fitzner J, Besselaar T, Jackson S, Vandemaele K, Zhang W. Review of the 2015 influenza season in the Southern Hemisphere. Wkly Epidemiol Rec. 2015;90:645-60.
   PubMedGoogle Scholar
• World Health Organization. Review of global influenza activity, October 2015-October 2016. Wkly Epidemiol Rec. 2016;91:604-22.
   PubMedGoogle Scholar
• Barbieri M, Silvestri R, Boccalini S, de Waure C. Analisi di costo-efficacia della vaccinazione anti-influenzale in Italia. Ital J Publ Health. 2015;4:70-84. Article no. 5.
   Google Scholar
• Pitrelli A. Introduction of a quadrivalent influenza vaccine in Italy: a budget impact analysis. J Prev Med Hyg. 2016;57:E34-40.
   PubMedGoogle Scholar
• Uhart M, Bricout H, Clay E, Largeron N. Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe. Hum Vaccin Immunother. 2016;12:2259-68. doi:10.1080/21645515.2016.1180490.
   PubMed Web of Science ®Google Scholar
• Associazione Italiana Economia Sanitaria. Proposta di linee guida per la valutazione economica degli interventi sanitari. Poilitiche Sanitarie. 2009;10:91-9.
   Google Scholar
• Meier G, Gregg M, Poulsen Nautrup B. Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the U.K. J Med Econ. 2015;18:746-61. doi:10.3111/13696998.2015.1044456.
   PubMed Web of Science ®Google Scholar
• Haq K, McElhaney JE. Immunosenescence: influenza vaccination and the elderly. Curr Opin Immunol. 2014;29:38-42. doi:10.1016/j.coi.2014.03.008.
   PubMed Web of Science ®Google Scholar
• Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine. 2012;30:1993-8. doi:10.1016/j.vaccine.2011.12.098.
   PubMed Web of Science ®Google Scholar
• Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess. 2003;7: iii-iv, xi-xiii, 1-170.
   PubMedGoogle Scholar
• Ministero della Salute. Prevenzione e controllo dell'influenza: raccomandazioni per la stagione 2016–2017; 2016 [accessed 2017 Jun 7]. http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2016&codLeg=55586&parte=1%20&serie=null.
   Google Scholar
• The Council of the European Union. Council recommendation on seasonal influenza vaccination; 2009 [accessed 2017 Jun 9]. http://ec.europa.eu/health/ph_threats/com/Influenza/docs/seasonflu_rec2009_en.pdf.
   Google Scholar
• World Health Assembly. Prevention and control of influenza pandemics and annual epidemics. Fifty-sixth World Health Assembly; Resolution WHA56.19; 2003 [accessed 2017 Jun 9]. http://www.who.int/immunization/sage/1_WHA56_19_Prevention_and_control_of_influenza_pandemics.pdf.
   Google Scholar
• Drummond MF, Schulfer MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford (UK): Oxford University Press, 2005.
   Google Scholar
• Chit A, Roiz J, Aballea S. An assessment of the expected cost-effectiveness of quadrivalent influenza vaccines in Ontario, Canada using a static model. PLoS One. 2015;10:e0133606. doi:10.1371/journal.pone.0133606.
   PubMed Web of Science ®Google Scholar
• Istituto nazionale di statistica. Popolazione residente al 1° Gennaio 2016 per età, sesso e stato civile; 2016 [accessed 2017 Jun 7]. http://demo.istat.it/pop2016/index.html.
   Google Scholar
• Istituto nazionale di statistica (ISTAT). Aspetti della vita quotidiana: classi di età; 2016 [accessed 2017 Jan 3]. http://dati.istat.it/Index.aspx?DataSetCode=DCCV_AVQ_PERSONE1&Lang.
   Google Scholar
• Istituto nazionale di statistica (ISTAT). Tavole di mortalità della popolazione residente. Ripartizione: Italia – Maschi e femmine – Anno: 2015; 2016 [accessed 2017 Jun 7]. http://demo.istat.it/tvm2016/index.php?lingua=ita.
   Google Scholar
• InfluNet. Sorveglianza Virologica. Rapporti sulle epidemie di influenza; 2016 [accessed 2017 May 10]. http://www.iss.it/fluv/index.php?lang=1&anno=2016&tipo=13.
   Google Scholar
• EpiCentro. Influenza. FluNews: archivio; 2017 [accessed 23 Mar 2018]. http://www.epicentro.iss.it/problemi/influenza/FluNewsArchivio.asp.
   Google Scholar
• Scalone L, Cortesi PA, Ciampichini R, Cesana G, Mantovani LG. Health related quality of Life norm data of the general population in Italy: results using the EQ-5D-3L and EQ-5D-5L instruments. Epidemiol Biostatistics Public Health. 2015;12:e11457.
   Web of Science ®Google Scholar
• Sander B, Kwong JC, Bauch CT, Maetzel A, McGeer A, Raboud JM, Krahn M. Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis. PLoS Med. 2010;7:e1000256. doi:10.1371/journal.pmed.1000256.
   PubMed Web of Science ®Google Scholar
• Centro nazionale per la prevenzione delle malattie e la promozione della salute. La sorveglianza Passi. Vaccinazione antinfluenzale. Trend annuale Copertura vaccinale nei 18–64enni con almeno una patologia cronica ITALIA; 2016 [accessed 2017 Jun 7]. http://www.epicentro.iss.it/passi/dati/VaccinazioneAntinfluenzale.asp.
   Google Scholar
• Ministero della Salute – ISS. Vaccinazione antinfluenzale in Italia: coperture vaccinali nella popolazione generale (per 100 abitanti) Stagioni 2000–2001/2015–2016; 2016 [accessed 2017 Jan 3]. http://www.salute.gov.it/imgs/C_17_tavole_19_allegati_iitemAllegati_0_fileAllegati_itemFile_3_file.pdf.
   Google Scholar
• Sessa A, Costa B, Bamfi F, Bettoncelli G, D'Ambrosio G. The incidence, natural history and associated outcomes of influenza-like illness and clinical influenza in Italy. Fam Pract. 2001;18:629-34.
   PubMed Web of Science ®Google Scholar
• Tricco AC, Chit A, Soobiah C, Hallett D, Meier G, Chen MH, Tashkandi M, Bauch CT, Loeb M. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med. 2013;11:153. doi:10.1186/1741-7015-11-153.
   PubMed Web of Science ®Google Scholar
• Ministero della Salute. Decreto 18 ottobre 2012. Nomenclatore dell'assistenza specialistica ambulatoriale; 2012 [accessed 2017 Jun 8]. http://www.salute.gov.it/portale/temi/p2_6.jsp?id=1767&area=programmazioneSanitariaLea&menu=lea.
   Google Scholar
• Ministero della Salute. Pronto Soccorso e sistema 118. Proposta metodologica per la valutazione dei costi dell'emergenza; 2007 [accessed 2017 Jun 9]. http://www.mattoni.salute.gov.it/mattoni/documenti/11_Valutazione_costi_dell_emergenza.pdf..
   Google Scholar
• Cicchetti A, Ruggeri M, Gitto L, Mennini FS. Extending influenza vaccination to individuals aged 50–64: a budget impact analysis. Int J Technol Assess Health Care. 2010;26:288-93. doi:10.1017/S0266462310000280.
   PubMed Web of Science ®Google Scholar
• Chamber of Commerce of Milan. Influenza: The costs for companies in Italy is already 33 million [article in Italian]; 2015 [accessed 2017 Aug 11]. http://www.milomb.camcom.it/c/document_library/get_file?uuid=73ae53c7-921e-42d1-9cfb-d948f588151d&groupId=10157.
   Google Scholar
• Marcellusi A, Viti R, Capone A, Mennini FS. The economic burden of HCV-induced diseases in Italy. A probabilistic cost of illness model. Eur Rev Med Pharmacol Sci. 2015;19:1610-20.
   PubMed Web of Science ®Google Scholar
• McCabe C, Claxton K, Culyer AJ. The NICE cost-effectiveness threshold: what it is and what that means. Pharmacoeconomics. 2008;26:733-44.
   PubMed Web of Science ®Google Scholar